This Might Be The HIV Cure We've Been Waiting For
Some much-needed good news this week.
We may soon have a cure for the Human Immunodeficiency Virus (HIV).
Scientists from the National Institute of Health (NIH) just identified an antibody in an HIV-infected patient that “neutralized 98 percent of HIV isolates tested, including 16 of 20 strains resistant to other antibodies of the same class,” according to a statement. That antibody is called N6, and its ability to shut down that many HIV strains is something scientists haven’t seen before.
HIV has been a really hard virus to fight because it “rapidly changes its surface proteins to evade recognition by the immune system,” according to the NIH statement. Science Alert expands on the problem, reporting that “due to HIV’s ability to rapidly respond to the body’s immune defences, an antibody that can block a wide range of strains has been very hard to come by.” Now that scientists have found an antibody that can do that, Science Alert reports the antibody “could form the basis of a new vaccine against the virus.”
The antibody, named N6, “blocks infection by binding to a part of the HIV envelope called the CD4 binding site, preventing the virus from attaching itself to immune cells,” reports NIH. That site, known as the V5 region, changes very little across all strains of HIV and is “the major mechanism of resistance to VRC01-class antibodies,” according to the study, published in the journal Immunity. By binding to it, N6 is able “to tolerate changes in the HIV envelope,” reports NIH, and bypass the resistance the virus forms to other antibodies. In doing that, N6 is able to prevent HIV from attaching, attacking, and ultimately destroying a patient’s immune cells, “which is what makes HIV-positive people so vulnerable to AIDS,” reports Science Alert.
N6 antibody binding to CD4. Credit: Immunity.
"The discovery and characterisation of this antibody with exceptional breadth and potency against HIV provides an important new lead for the development of strategies to prevent and treat HIV infection," said Anthony S. Fauci from the US National Institute of Allergy and Infectious Diseases in the NIH statement.
The technique is about to be tested in humans in a Phase II clinical trial; right now, it’s only been done on Rhesus monkeys. But it offers a much-needed ray of hope to HIV patients.
Fingers crossed the good news continues through the trial.
Since the idea of locality is dead, space itself may not be an aloof vacuum: Something welds things together, even at great distances.
- Realists believe that there is an exactly understandable way the world is — one that describes processes independent of our intervention. Anti-realists, however, believe realism is too ambitious — too hard. They believe we pragmatically describe our interactions with nature — not truths that are independent of us.
- In nature, properties of Particle B may be depend on what we choose to measure or manipulate with Particle A, even at great distances.
- In quantum mechanics, there is no explanation for this. "It just comes out that way," says Smolin. Realists struggle with this because it would imply certain things can travel faster than light, which still seems improbable.
E-cigarettes may be safer than traditional cigarettes, but they come with their own risks.
- A new study used an MRI machine to examine how vaping e-cigarettes affects users' cardiovascular systems immediately after inhalation.
- The results showed that vaping causes impaired circulation, stiffer arteries and less oxygen in their blood.
- The new study adds to a growing body of research showing that e-cigarettes – while likely safer than traditional cigarettes – are far from harmless.
The Russian-built FEDOR was launched on a mission to help ISS astronauts.